Skip to content
Screener

Veracyte VCYT Product revenue — License fees and royalties

Similar metrics at other companies

Wyndham Hotels & Resorts, Inc. logo
WHLicense and other fees — Royalties and franchise fee revenues
$32M-3.0%
Kopin logo
KOPNLicense And Royalties — Revenue
$64.93K-9.7%
Wyndham Hotels & Resorts, Inc. logo
WHRoyalties and franchise fees — Royalties and franchise fee revenues
$139M-5.4%
SoundHound AI, Inc. logo
SOUNProduct royalties — Revenue
$8.35M+87.8%
OneSpan logo
OSPNProduct and license — Revenue
$35.51M-4.7%
Wyndham Hotels & Resorts, Inc. logo
WHManagement fees — Royalties and franchise fee revenues
$2M0.0%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept vcyt:CostOfRevenueLicenseFeesAndRoyalties.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Line itemThree Months Ended March 31, 20262025
Total cost of testing revenue33,30628,260
Cost of product revenue:
Product costs1,401109
License fees and royalties313324
Other cost of product revenue (2)174792
Allocation of facilities and IT expenses3197
Total cost of product revenue1,8911,422
Cost of biopharmaceutical and other revenue:

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's product revenue — license fees and royalties?
Veracyte (VCYT) reported product revenue — license fees and royalties of $313K in Q1 2026.
How has Veracyte's product revenue — license fees and royalties changed year-over-year?
Veracyte's product revenue — license fees and royalties decreased by 3.4% year-over-year, from $324K to $313K.
What is the long-term trend for Veracyte's product revenue — license fees and royalties?
Over 3 years (2022 to 2025), Veracyte's product revenue — license fees and royalties has grown at a 3.5% compound annual growth rate (CAGR), from $1.09M to $1.21M.
What does product revenue — license fees and royalties mean?
This metric represents the costs associated with licensing intellectual property or paying royalties required to manufacture or sell products within the segment. These expenses are often tied to third-party technology or patent rights necessary for product commercialization. It provides insight into the company's reliance on external technology and the associated cost burden on product profitability.

Ask your AI about Veracyte's product revenue — license fees and royalties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude